Article | Open | Published:

A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis

Nature Communicationsvolume 9, Article number: 2243 (2018) | Download Citation

Abstract

It is unknown how chronic inflammation impacts the brain. Here, we examined whether higher levels of peripheral inflammation were associated with brain connectivity and structure in 54 rheumatoid arthritis patients using functional and structural MRI. We show that higher levels of inflammation are associated with more positive connections between the inferior parietal lobule (IPL), medial prefrontal cortex, and multiple brain networks, as well as reduced IPL grey matter, and that these patterns of connectivity predicted fatigue, pain and cognitive dysfunction. At a second scan 6 months later, some of the same patterns of connectivity were again associated with higher peripheral inflammation. A graph theoretical analysis of whole-brain functional connectivity revealed a pattern of connections spanning 49 regions, including the IPL and medial frontal cortex, that are associated with peripheral inflammation. These regions may play a critical role in transducing peripheral inflammatory signals to the central changes seen in rheumatoid arthritis.

Introduction

When people experience injury or infection, their behaviour and perceptions change dramatically. These changes tend to be conserved across mammalian species and include increased sensitivity to pain, fatigue and cognitive dysfunction. These are collectively referred to as ‘sickness behaviours’1. The primary mechanisms through which these changes occur are inflammatory—molecular messengers of damage and infection signal the central nervous system (CNS) through afferent nerves, sentinel cells in the circumventricular organs and transport across the blood–brain barrier (BBB)1. However, the neural correlates of inflammation in chronic conditions have scarcely been explored. Chronic conditions characterized by both heightened inflammation and symptoms like fatigue and neurocognitive deficits include diabetes, cancer, dementia and rheumatoid arthritis (RA)2,3,4,5,6. Experimental paradigms in small samples of healthy individuals who receive immunogenic substances have demonstrated transient alterations in functional connectivity of the brain7,8. These effects, however, represent the response of the resilient CNS to acute inflammatory insults, and studies of how symptoms change over longer-term administration of immunogenic substances suggest potentially important differences in the central response to chronic vs. acute inflammation9. Characterizing the neuro–immune axis in chronic inflammatory conditions represents a crucial link in determining how repeated inflammatory insults result in debilitating symptoms in RA.

In this study, we leverage the natural fluctuations in levels of peripheral inflammation that are a feature of RA in order to determine how inflammation affects brain function and structure. RA is ideal for these purposes because the condition is archetypically inflammatory and chronic6, with most sufferers experiencing periodic disease flares wherein both circulating inflammatory markers and symptoms become elevated. Our primary objectives were to identify specific brain regions that become more or less connected with each other as levels of inflammation increase. This was accomplished by first conducting a whole-brain search using Independent Component Analyses (ICA) to identify relationships with established neural networks. Second, we expanded on this approach using graph theoretical analyses to identify relationships with inflammation across the entire functional connectome. Finally, we employed voxel-based morphometry (VBM) to identify areas where grey matter (GM) volume is increased or decreased in conjunction with levels of inflammation. To confirm the validity of our results, we repeated ICA analyses in the same individuals 6 months later. Our purpose was to identify, among patients with RA, brain regions and patterns of connectivity that are important in the central response to peripheral inflammation. We find that the left inferior parietal lobule (IPL) and medial prefrontal cortex (mPFC) play critical roles in the altered patterns of brain connectivity associated with peripheral inflammation in RA.

Results

Sample

Fifty four RA patients underwent magnetic resonance imaging (MRI) at baseline and at 6 months (mean age 54.94 ± 11.41 years; n = 41 (76%) female; mean disease duration 11.49 ± 8.64 years) of a total of 335 patients who were approached (Supplementary Figure 1). There was variation in the primary clinical indication of inflammation, erythrocyte sedimentation rate (ESR; range: 2–62 mm/h at the baseline visit) and clinical presentation of RA. Clinical characteristics, including ESR, C-reactive protein (CRP), Disease Activity Score −28 (a composite of swollen joint counts, ESR and self-rated health)10, and symptom levels at each time are displayed in Fig. 1 (and see Supplementary Table 1). A number of anti-inflammatory medications were used by the sample (Supplementary Table 2).

Fig. 1
Fig. 1

Box plots of clinical characteristics and symptoms at baseline and 6 months for 54 rheumatoid arthritis patients. The center line represents the median value, the lower bound of the box represents the 25th percentile, the upper bound of the box the 75th percentile, and the whiskers represent minimum and maximum values, or 1.5 times the interquartile range in the presence of outliers, which are indicated by dots or asterisks

Seed network to whole-brain connectivity analysis

Eight functional brain networks identified through ICA11 were used as seeds in a whole-brain search to identify specific brain regions that become more positively or negatively connected to the seed network at higher levels of peripheral inflammation (ESR). These analyses revealed several significant associations between higher ESR and positive functional brain connections and a single association with a negative functional connection. Four of the eight networks (default mode network (DMN), dorsal attention network (DAN), salience network (SLN), medial visual network (MVN)) showed these relationships (Table 1 and Fig. 2). Two brain regions showed connections to multiple networks, roughly comprising the left (L) IPL /L angular gyrus and the bilateral mPFC (Fig. 3). The other four networks (sensorimotor network (SMN), lateral visual network, left and right fronto-parietal perception/language networks) showed no significant relationships. As noted in Table 1, six of the eight identified patterns of connections between regions and seed networks were also associated with higher levels of CRP. Three of these relationships were replicated at the second session with ESR at a trend level (L IPL to DMN, L IPL to DAN, right (R) mPFC to DAN) while five of the eight identified connections were replicated with CRP (L IPL to DMN, R PCC to DMN, L IPL to DAN, R mPFC to DAN, L IPL to MVN). See Fig. 4 and Table 2.

Table 1 Seed network to whole-brain connectivity analyses at baseline
Fig. 2
Fig. 2

Inflammation-associated functional connectivity patterns. Brain regions (medial prefrontal cortex [mPFC], inferior parietal lobule [IPL]) showing positive connections to the default mode network (DMN; a), dorsal attention network (DAN; b, c), medial visual network (MVN; d), and salience network (SLN; e, f) at higher levels of peripheral inflammation. Scatterplots showing the strength connectivity and levels of erythrocyte sedimentation rate (ESR) are displayed below brain images. All associations were detected using seed networks identified by independent component analysis in a whole-brain search with ESR as the primary predictor of interest controlling for age and sex with p < 0.05 false discovery rate (FDR) cluster corrected for multiple comparisons

Fig. 3
Fig. 3

Overlap of inflammation-associated functional connectivity changes. a Brain regions (medial prefrontal cortex [mPFC], inferior parietal lobule [IPL]) showing positive connectivity to the different networks (medial visual network [MVN], default mode network [DMN], dorsal attention network [DAN], salience network [SLN]) at higher levels of peripheral inflammation measured by erythrocyte sedimentation rate (ESR). Area of reduced grey matter volume is shown in light blue. This was identified by testing the association of ESR with grey matter volume derived through voxel-based morphometry (VBM) in 8 mm spheres extracted around the significant peak cluster coordinates from the session 1 network to whole-brain connectivity analyses, in multiple linear regression analyses controlling for age and sex at p < 0.05 uncorrected. b Scatterplot showing the association between ESR and grey matter volume. Displayed at p = 0.005 voxel threshold corrected for age and sex

Fig. 4
Fig. 4

Overlap of inflammation-associated functional connectivity at both time points. a Positive connections between the default mode network (DMN) with the inferior parietal lobule (IPL), b dorsal attention network (DAN) and IPL, c the DAN and medial prefrontal cortex (mPFC) at baseline and 6 months that were associated with increased peripheral inflammation measured by erythrocyte sedimentation rate (ESR). Scatterplots showing the association between ESR and the strength of connectivity are displayed next to each brain region. Extracted average Fisher r values from 8 mm spheres derived from the significant peak cluster coordinates identified at session 1 (baseline) were used at session 2 (month 6) and these were correlated with concurrent ESR values using Pearson correlations at p < 0.05 uncorrected. Baseline regions are shown in orange, 6 months in blue. Displayed at p = 0.005 voxel threshold

Table 2 Region-of-interest functional connectivity replication analysis at 6 months

Network-Based Statistic

To explore more detailed patterns of inflammation-linked functional connectivity, all pairwise connections between 264 brain regions12 were examined for subsets of brain regions (nodes) that are positively connected to one another (edges) at higher levels of peripheral inflammation. This approach uses a Network-Based Statistic (NBS)13 derived from graph theoretical network analysis14 to identify the relevant nodes and edges. Higher levels of ESR were associated with a significant NBS configuration comprised of 49 nodes and 54 edges. These are depicted visually in Fig. 5, and the nodes are listed in Table 3 (edges in Supplementary Table 3). Using the consensus network assignment of Power’s atlas12, these nodes belonged most frequently to the fronto-parietal task control (nine nodes), default mode (eight nodes) and salience (seven nodes) networks.

Fig. 5
Fig. 5

Summary of inflammation-associated functional connectivity changes. a Nodes and edges showing the Network-Based Statistic (NBS) inflammation configuration, with scatterplot showing the association (Pearson correlation) between erythrocyte sedimentation rate (ESR) and the average strength of connectivity across the 54 edges. Undirected and weighted Fisher z-transformed bivariate correlation matrices of connectivity were created for each subject from 10 mm diameter spheres at the 264 nodes of the Power atlas (264 × 264 matrices). Identified nodes and edges associated in aggregate with higher ESR are derived from permutation testing at family wise error corrected p < 0.05. b Overlap of regions of positive connectivity identified through seed network to whole-brain analyses and nodes identified through NBS analyses of higher inflammation

Table 3 Network-Based Statistic nodes for the inflammation configuration

The L IPL/angular was well-represented in the NBS configuration, as five of the eight nodes that correspond approximately to the L IPL/angular region in the Power's atlas were present. Three of these five nodes were located in the L IPL region identified through the network to whole-brain connectivity analyses (regions 86, 87, 177). Similarly, three nodes were located in the medial frontal/orbital region, one of which was located in the medial frontal region identified through the network to whole-brain connectivity analyses (region 75). The three nodes that overlapped with the ICA findings in the IPL collectively participated in 10 of the 54 edges in the ‘inflammation configuration’, while the medial frontal node participated in three. Edges showed a diverse range of connections, including connections within the L IPL/L angular and connections from the L IPL to regions of the putative pain matrix such as the dorsal anterior cingulate cortex and anterior insula.

Hub analyses

Brain regions can be defined as hubs if they a large number of rich connections to other brain regions, a measure called eigenvector centrality (EC)15. Four nodes located in the L IPL region identified through seed network to whole-brain analyses were classified as hubs. Of the 49 nodes in the NBS inflammation configuration, 17 were classified as hubs. These are noted in Table 3 (all identified hubs are shown in Supplementary Table 4).

EC and the inflammation configuration

The EC score, a measure of overall hub-like qualities, derived from the 49 NBS nodes was positively associated with ESR (r = 0.466, p < 0.001; Pearson correlation). This indicates that the nodes comprising the ‘inflammation configuration’ are increasingly hub-like in their role in the whole-brain functional connectome in individuals with higher levels of peripheral inflammation.

Region-of-interest VBM analyses

Of the significant functional connectivity regions identified in Table 1, higher levels of ESR were associated with reduced GM volumes of the L IPL (B = −0.00032; multiple linear regression; p = 0.038 age/sex/total intracranial volume [TIV] corrected and posterior cingulate cortex (B = −0.00050; multiple linear regression; p = 0.024). This result did not meet false discovery rate (FDR) correction, a method for controlling for multiple comparisons (p > 0.05 FDR). Results of each region of interest (ROI) analysis are shown in Table 4.

Table 4 Region-of-interest-based analyses of grey matter volume using voxel-based morphometry

Whole-brain VBM

One region of reduced GM volume was identified that was associated with higher levels of ESR. This was a region that included the L Cerebellum and L lingual gyrus (MNI coordinates: −4, −85, −21; z value: 4.07; cluster size: 2213 voxels; FDR-corrected p < 0.001). There were no relationships with increased GM volume.

The association between ESR and the GM volume of the L IPL was replicated in session 2 6 months later (B = −0.00031; multiple linear regression; p = 0.035 age/sex/TIV corrected), whereas the relationship with the posterior cingulate cortex was not (B = −0.00029; multiple linear regression; p = 0.13). Similar to the baseline results, this finding in the L IPL did not meet FDR correction (p > 0.05 FDR).

Associations with symptoms

Different clinical domains of RA were also associated with identified functional connections. Increased functional connectivity between the DAN and R mPFC correlated with increased levels of fatigue (r = 0.46), pain intensity (r = 0.36) and diffuse pain (r = 0.34; all p < 0.05; Pearson correlation). Enhanced functional connectivity of the SLN–L IPL/angular (r = 0.34), and DMN–L IPL (r = 0.28) were associated with more diffuse pain (both p < 0.05; Pearson correlation). Increased SLN–L mPFC connectivity was associated with more diffuse pain (r = 0.27) and a lower percentage of correct responses on the paced auditory serial addition test (PASAT; r = −0.28; both p < 0.05; Pearson correlation). All of the tested associations are displayed in Table 5.

Table 5 Pearson correlations between functional connections and clinical symptoms

Discussion

These are some of the first analyses to identify brain regions that play an outsized role in inflammation-linked functional brain connectivity among patients with a chronic inflammatory disease. These regions were identified through converging analytic strategies. Our primary analysis used a seed network to whole-brain approach and found that multiple established intrinsic connectivity networks showed greater positive connections to the L IPL and bilateral mPFC in individuals with higher levels of inflammation. These findings were expanded upon and supported by unsupervised graph-theory-based analyses examining all pairwise connections across the whole brain. These analyses revealed a configuration of nodes and edges that have more positive connections in individuals with higher levels of inflammation. Together these analyses suggested that some structures of the brain—particularly the L IPL—are important for the altered pattern of connectivity we observed in RA patients with higher levels of peripheral inflammation. Seed network to whole-brain analyses were replicated at the trend level 6 months later for the L IPL to DMN and for the L IPL and R mPFC to DAN, suggesting some stability of these results. Graph theoretical analyses showed that, while the L IPL and medial frontal are indeed important for inflammation-associated connectivity, they are part of a larger configuration of more positive connections involving many brain regions that participate in sustained attention and working memory. While nearly one fifth of the nodes in the whole brain participated in this configuration, only a very small fraction of possible connections were involved, and these generally involved more positive connections between the DMN, the DAN and the fronto-parietal task control networks. An analysis of the centrality of these nodes found that the brain regions making up the ‘inflammation configuration’ become increasingly prominent in the landscape of global functional connectivity in individuals with higher inflammation. Secondary analyses showed that there was also reduced GM volume in the L IPL. Finally, these patterns of inflammation-linked positive connectivity between the L IPL, bilateral mPFC and seed networks were associated with clinical symptoms of RA, including more widespread pain, fatigue, pain severity and a worse performance on the PASAT. These findings are strengthened by the agreement of some of the functional and structural outcomes and the broad agreement of analytic strategies. We conclude that the L IPL and mPFC are regions critical to the central response to peripheral inflammation in RA and may be part of a broader pattern of inflammation-linked network reorganization.

Increases in ESR and CRP are indices of overall disease activity in RA and, together with pain/tenderness and swollen joints, represent an important metric for disease severity and a benchmark for the success of treatment16. During heightened disease activity in RA, the balance of inflammatory factors skews towards production of pro-inflammatory mediators as a result of increased autoimmune activity6,17. These molecular signals subsequently reach the CNS through distal afferent nerves with cytokine receptors, sentinel immune cells embedded in the circumventricular organs outside the BBB, cytokine receptors on perivascular immune cells in the CNS and by active transport across the BBB when a sufficient circulating concentration of cytokines is reached1. Elevations in ESR and CRP then almost certainly represent increased activity along the various pathways1 that induce ‘sickness behaviours’ under conditions of acute inflammation. Accordingly, anti-cytokine therapies represent some of the most effective and widely used treatments for RA and appear to alter CNS responses to painful stimuli18. In the current study, symptoms analogous to ‘sickness behaviours’ were associated with inflammation-linked altered connectivity. These included greater fatigue and pain intensity, more widespread pain or tenderness and a worse performance on the PASAT—positive connections between the mPFC and DAN specifically were associated with both fatigue and pain outcomes. In RA, fatigue and pain are closely linked19, so identifying common neural substrates of these symptoms could help determine whether and how anti-inflammatory treatment alters the CNS.

To date, the most compelling evidence of inflammation-linked changes in neuroimaging outcomes come from studies of healthy people given immunogenic substances such typhoid vaccine or lipopolysaccharide (LPS). Both of these substances yield transient (i.e. hours) increases in circulating levels of pro-inflammatory cytokines, such as interleukin (IL)-620,21. The mPFC region shown to play a role in the current study has been previously identified in studies employing experimental inflammatory paradigms. Healthy individuals administered LPS showed increased activation of the right medial frontal gyrus during social tasks with emotional valence22,23 These findings may be relevant to the greatly impaired mental health and social function seen in chronic inflammatory conditions like RA24. However, in acute inflammatory paradigms with healthy individuals, distinct patterns of reduced connectivity between insula, amygdala, frontal and parietal regions have also been demonstrated using seed-based analyses25, in contrast to the current study, where more positive connections were identified in association with higher inflammation.

Conceptually, an acute inflammatory insult would be expected to impact established neural networks to promote short-term changes in behaviour—the classic repertoire of sickness behaviours. In RA, the transient surges in inflammation occur in the context of increased basal levels of inflammation, as well as many previous inflammatory events, especially if the disease has been poorly controlled. This means the neural pathways that transduce inflammation into behaviour and symptoms in chronic conditions such as RA likely involve a more fundamental pattern of reorganization. This distinction is suggested by studies that follow the administration of potent pro-inflammatory treatments in cancer patients: fatigue and lethargy tend to develop rapidly (i.e. within 2 weeks) while more obvious neurocognitive complaints do not appear until several weeks later9. In the current study, we found an ‘inflammation configuration’ that was not particularly rich in brain regions meeting hub status—however, in individuals with higher ESR, these regions showed greater hub-like qualities, perhaps pointing to the hypothesized reorganization.

Cognitive processes supporting working memory, sustained attention and persistence through distraction involve complex interactions of neural networks. While the DMN is sometimes called a ‘task-negative’ network, it is becoming clear that DMN resources are recruited during complex tasks26. It was recently shown that, as the complexity of a working memory task increases, the global modularity of the brain decreases, meaning that the brain’s subnetworks are increasingly likely to change their configurations in response to the demands of the task27. Furthermore, the DMN plays a major role in this network flexibility, and the nodes that make up the DMN, along with the DAN, and fronto-parietal task control network are some of the most likely to change patterns of connectivity in response to task demands27. These are the same three subnetworks that comprise a significant portion of the configuration we find in the current analyses that become more positively connected to one another at higher levels of peripheral inflammation. It is possible then that the inflammation-linked changes in connectivity observed here serve a compensatory function—conscription of neural resources to perform normal cognitive tasks. This would seem to echo the overactivation seen in the aging brain during cognitive tasks28. Though speculative, this network conscription mechanism would be consistent with an adaptive response to impairment that does not resolve within days or hours, as it does in studies of acute inflammation.

Two findings in the current study—decreased GM volume in patients with higher peripheral inflammation and worse performance on the PASAT in association with inflammation-linked altered connectivity—are relevant in light of the mounting evidence that RA may confer an increased risk of developing dementia29. It is hypothesized that the basis of this risk is uncontrolled inflammatory activity, as a nested case–control study of RA patients has shown that the increased risk of Alzheimer’s disease is attenuated significantly by anti-cytokine therapy30. The GM volume reduction noted in the cerebellum in association with higher peripheral inflammation was a robust finding—recent studies have found evidence that the cerebellum is selectively affected in Alzheimer’s disease31,32. We also found, using ROI analyses based on our functional connectivity findings, that both the L IPL and posterior cingulate cortex showed reduced GM volume in individuals with higher inflammation. The L IPL and posterior cingulate are regions that have been identified using emerging positron emission tomographic imaging methods with the 11C-PBR28 ligand, a putative marker of activated CNS microglia and astrocytes33,34, as areas of increased neuroinflammatory activity in Alzheimer’s disease35. Remarkably, the degree of neuroinflammation in these regions was also associated with reduced GM volume and worse neuropsychological test performance35. Because the L IPL and posterior cingulate were also areas that showed altered connectivity in connection with higher inflammation, it is possible that altered functional connectivity is a consequence of these structural deficits. It is even possible that these changes are early harbingers of more serious neurocognitive decline later in life.

ESR and CRP are metrics of inflammatory activity but do not show the same level of mechanistic specificity as pro-inflammatory cytokines, such as IL-6, tumour necrosis factor (TNF)-α and IL-1β. These and other inflammatory actors should be measured in future studies of these phenomenon. The study visits did not occur within a standardized window and diurnal variation in inflammatory and imaging outcomes are possible. These findings are based on a relatively limited assessment of clinical symptoms of RA and neurocognitive performance. It is perhaps unsurprising that the subnetworks not identified in the current study are generally associated with tasks dissimilar to the PASAT, such as fine motor skills and language processing. It will be important to expand assessment in future studies to more diverse measures of neuropsychological performance and to clinical symptoms of RA, as these will likely involve their own distinct patterns of functional connectivity. Future studies in RA and other chronic inflammatory conditions should explore sex-specific differences in the impact of inflammation on neural networks as there is evidence for these differences in acute inflammatory paradigms23. Similarly, we used only task-based connectivity in the current analyses. A robust assessment of intrinsic/resting connectivity may produce interesting contrasts to the current findings. The NBS technique is meant to test the overall significance of a group of connections; each individual edge and node should be interpreted with caution.

These results demonstrate altered patterns of brain connectivity in RA patients with higher peripheral inflammation and may show evidence of distinct inflammation-associated subnetwork reorganization. Treatments for RA that successfully control peripheral inflammation should be investigated to determine whether they normalize brain network activity or have a neuroprotective effect. These results may have relevance for other chronic inflammatory conditions as well.

Methods

Design and sample

RA patients attending a UK regional rheumatology service were consecutively approached. Those who fulfilled the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria36 and who experienced fatigue for >3months at clinically significant levels (defined as a score of >3 on the Chalder fatigue binary scale37) were considered eligible for this observational cohort study. Patients with contra-indications to MRI (e.g. metal implants), alternative medical explanations for fatigue (symptomatic cardio-respiratory disease, a history of cancer in previous 5 years, unstable thyroid disease, beta-blocker prescription) or left handed were excluded. A sample size of 50 or greater was the goal of recruitment, as this provides power to detect moderate-sized correlations at relatively conservative thresholds (i.e., r = 0.46 for α = 0.001), a sample size believed to perform well in the unbiased ROI-based functional connectivity analyses described below38. All ethical guidelines were followed during the conduct of the study and ethical approval for the study was obtained from the North of Scotland Research Ethics Committee. All participants gave full informed written consent according to the Declaration of Helsinki.


Procedure

All consenting participants underwent a clinical assessment phenotyping battery and multi-modal MRI brain scan. The full procedure was repeated at a second session, 6 months later.

The primary clinical outcome of interest was inflammation as measured by ESR. A measure of red blood cell aggregation, which is enhanced by inflammatory processes, ESR is one of the most widely use laboratory measures of systemic inflammation in clinical medicine and has a long standing role in aiding the diagnosis and monitoring of chronic inflammatory diseases, such as RA39. In RA, ESR and CRP are elevated during times of active disease, as are acute-phase pro-inflammatory cytokines, such as IL-6, TNF-α, and IL-1β40,41. While ESR is a relatively non-specific measure of inflammation, it does correlate moderately with almost all other metrics of inflammatory activity, including elevations of pro-inflammatory cytokines42 and systemic glucocorticoid activation43. Venous blood was drawn by a trained phlebotomist as part of routine clinical practice during normal hours (approximately 9 a.m.–5 p.m.). Blood was immediately processed and analysed for the calculation of ESR (Westergren method). CRP was also analysed immediately from serum with an ADVIA® XPT immunoassay System (Siemens).

Secondary clinical outcomes of interest were (1) acute inflammation as measured by CRP, another broad marker of systemic inflammation which is routinely employed in practice. This acute phase protein is a downstream response to elevated levels of pro-inflammatory cytokines such as IL-6; it is considered a more sensitive marker of acute inflammation compared with ESR44. (2) Phenotypic features of sickness behaviour/clinical symptoms of RA, including (a) current levels of fatigue and pain severity, separately assessed by answering on a 0–10 numerical rating scale, (b) spatial extent of pain, as measured by the widespread pain index component of the 2011 Fibromyalgia survey criteria45 and (c) performance (% correct) on the PASAT46.


MRI brain measures

Images were acquired by a 3 Tesla, 8 channel phased array head coil using three-dimensional (3D) T1- and T2*-weighted gradient-echo echo-planar imaging (EPI) pulse sequences.


Overview of functional connectivity

The functional sequences were obtained using a block design where the PASAT was undertaken during 3 × 3 min ‘on’ periods and interspersed by 4 × 30 s rest or ‘off’ periods. The PASAT is a validated measure of cognitive function (specifically auditory processing, calculation, working memory and attention) which has been employed in functional MRI (fMRI) paradigms46,47. Participants were asked to listen to a series of numbers ranging from 1 to 9. They were required to sum consecutive numbers (i.e. the first to the second, the second to the third, etc.) and to record, via a button press, every occasion two consecutive numbers summed to the number 10. Concurrently, they were asked to focus on a computer screen displaying three boxes containing random, rapidly changing numbers. This visual stimulus was intended to distract the participants from the auditory task and hence increase difficulty. They were instructed not to process the visual numbers in any way. We chose a paradigm based on connectivity during the PASAT because this particular procedure has been shown to induce transient mental fatigue in Chronic Fatigue Syndrome46, and in rheumatic autoimmune disease such as granulomatosis with polyangiitis47, and thus might reflect connectivity relevant to the clinical characteristics, such as ‘mental fog’, in RA. It is important to note that task-based connectivity reflects both intrinsic and task-specific activity48, and our current paradigm was not designed to dissociate these patterns.

A T2*-weighted single-shot EPI sequence [TR = 3000 ms, TE = 30 ms, flip angle (FA) = 90°, in-plane SENSE acceleration 2, matrix size 128 × 128 with 30 slices, field of view (FOV) = 240 mm, 1.88 × 1.88 × 5 mm3 voxels and 226 volumes] followed by a T1-weighted fast-field echo 3D structural scan for normalization (TR = 8.2 ms, TE = 3.8 ms, TI = 1018 ms FA = 8°, FOV = 240 mm, matrix size 240 × 240 matrix with 160 slices and 0.94 × 0.94 × 1 mm3 voxels) were acquired.


fMRI pre-processing

Using SPM8 (Wellcome Department of Cognitive Neurology, London, United Kingdom) running on MATLAB R2014a (Mathworks, Sherborn, MA, USA), the first four volumes were discarded to allow the magnetization to reach equilibrium, the remaining 222 functional images were realigned to the first image. The structural scans were then co-registered to a mean generated from the functional scans, after which they were segmented. The functional and structural scans were normalized to the standard SPM Montreal Neurological Institute template grey prior probability map via the individuals segmented GM image and then the functional scans were smoothed with an 8-mm full-width half-maximum (FWHM) Gaussian kernel.


Independent component analysis

Group ICA was performed using the Group ICA of fMRI Toolbox (GIFT) toolbox49. Employing pre-processed functional data from both sessions for all subjects, component estimates were validated using the Infomax ICA algorithm 20 times in ICASSO software. We used a moderate model order of 40 components to identify cortical and subcortical components that correspond to both anatomical and functional segmented networks. These included both the task and rest periods of the scan. Subject-specific spatial maps and time courses were estimated using the GICA3 back reconstruction method. Eight subnetworks identified through the ICA analyses were examined. These were the DMN, DAN, SLN, SMN, left and right fronto-parietal perception/language networks, MVN, and the lateral visual network. These represent subnetworks identified by Beckman et al. (2005)11 from studies of intrinsic connectivity that also strongly agree with task-based connectivity-derived networks50. Networks were identified and confirmed by spatial correlation between component maps and published template maps11. Spatial masks of the mean component map, for each intrinsic network identified, were created using the Marsbar toolbox for seed-based connectivity analyses.


Seed network to whole-brain connectivity analysis

Seed network to whole-brain connectivity was performed using the CONN (Cognitive and Affective Neuroscience Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA; www.nitrc.org/projects/conn) functional connectivity toolbox v15 in SPM851. White matter, cerebrospinal fluid (CSF) and motion parameters were entered into the analysis as covariates of no interest. A band pass filter (frequency window: 0.01–0.1 Hz) was applied to remove linear drifts and high frequency noise from the data. The seeds used were based on the spatial masks of the intrinsic networks generated from the ICA analyses. The onsets and durations of both task 'on' and rest 'off' periods were delineated in order to measure connectivity between the networks and the rest of the brain during each condition of the scanning period. First-level analysis included bivariate correlations between voxels within each network and all voxels throughout the whole brain, thereby creating separate beta maps for each individual at each session. Only the beta maps that measured network connectivity during the PASAT task 'on' period (9 total minutes) were passed onto group second-level analyses in SPM8. The rest periods were not used in these analyses as neither the total length of 'rest' time (2 min) nor the length of individual blocks (30 s) are conducive to connectivity analyses52.

Associations in network connectivity and ESR during the first session were assessed using a General Linear Model with age and sex entered as covariates of no interest. The resulting maps were thresholded at a whole-brain p < 0.001 uncorrected voxel threshold and p < 0.05 FDR cluster corrected for multiple comparisons. Significant regions were extracted from first-level network-to-whole-brain connectivity beta maps for each subject by obtaining the average Fisher transformed r values of the identified clusters. We then performed post-hoc Spearman rank-order correlations between functional connectivity and CRP to confirm the relationships seen with ESR. Finally, replication of these significant clusters were tested with an ROI analysis by extracting the average Fisher transformed r values of the 8 mm spheres—created around the significant peak cluster coordinates using the Marsbar toolbox53—from the relevant second session network connectivity maps and then correlating with the concurrent ESR value. These post-hoc analyses were conducted in STATA 12.1 (Stata, College Station, TX, USA), statistical significance was set at a p-value of 0.05 two-sided.


Graph theoretical analyses

Brain networks can be modelled using graph theoretical tools as a set of functional interactions made up of nodes (brain regions) and edges (functional connections between nodes)14. We defined the brain network using a set of 264 non-overlapping nodes based on resting-state and task functional connectivity meta-analyses12,54. This parcellation has been shown to produce reliable network topologies12,55,56. The 264 nodes were entered into the Conn Toolbox as 10 mm diameter spheres51. We created task-specific functional connectivity matrices by entering the onsets and durations of the PASAT task 'on' and rest 'off' periods in the Conn Toolbox as described above. A similar approach was used in a recently published study using graph theoretical analyses on task data27. Only the task blocks were concatenated (following our strategy in the seed network to whole-brain analyses) to create undirected and weighted Fisher z-transformed bivariate correlation (Pearson’s r) matrices (264 × 264) for each participant using the average signal from each of the 264 nodes described above.


The Network-Based Statistic

The NBS is a statistical method for evaluating large networks, first described by Zalesky et al. (2010)13. In the case of functional brain connectivity, the raw data are the set of all pairwise connections (edges) between parcellated brain regions (264 regions as described above). The purpose of the NBS is to statistically control for the large number of comparisons made whenever all the individual edges of a network are tested and to isolate a configuration or configurations of nodes and edges (brain regions and connections between regions) associated with a particular research question of interest. This paradigm has been employed, for instance, in studies of schizophrenia. Statistical significance is determined through permutation testing. First, every edge (connection) is tested individually according to a pre-specified critical threshold. For the current analysis, this test was whether each and every pairwise connection (34,980) increase or decrease in strength as levels of ESR increase (controlling for age and sex). The connections that exceed this threshold are then used in a procedure analogous to cluster identification that seeks to identify a group of edges that form a graph configuration. The resulting configuration is what is statistically tested via permutation methods (5000 repetitions), and a significant family-wise error (FWE)-corrected p-value indicates that the configuration is associated with higher levels of ESR. Here we use a t-value of 3.3, corresponding approximately to a p-value of 0.001, as our critical threshold. FWE significance was set at p < 0.05.


Hub analyses

We calculated a measure of centrality, EC, to assess the relative global importance (hub status) of a node within the whole-brain network15. The EC accounts for the quantity and quality of connections by taking into account the centrality of a node and the centrality of that node’s neighbours. See ref.57 for a detailed description and mathematical formulations of this measure. EC was calculated using the Brain Connectivity Toolbox51. We assigned hub status to a node if the EC was greater than one standard deviation above the group mean58. We quantified the number of nodes in our NBS-derived configuration that met hub status by EC. To determine whether the global centrality of the nodes in the NBS configuration were associated with inflammation, we created a composite NBS EC score for each individual. This was accomplished by standardizing each EC measure for each of the 49 nodes into z-scores and averaging these for each individual. The resulting score was then correlated with ESR using Pearson correlations. The purpose of this analysis was to determine whether the nodes that make up the inflammation configuration take on a more or less prominent role in the whole-brain network topology in conjunction with rising peripheral inflammation.


Overview of VBM

Inspection of each T1-weighted fast-field echo data set and normalization (TR = 8.2 ms, TE = 3.8 ms, TI = 1018 ms FA = 8°, FOV = 240 mm, matrix size 240 × 240 matrix with 160 slices and 0.94 × 0.94 × 1 mm3 voxels) revealed no gross anatomical abnormalities.


VBM pre-processing

Inspection of each T1-weighted structural image (acquisition parameters described above) revealed no gross anatomical abnormalities. The images were then pre-processed in SPM8 (http://www.fil.ion.ucl.ac.uk/spm) using the Diffeomorphic Anatomical Registration using the Exponential Lie Algebra (DARTEL) toolbox59. First, the images were segmented into GM and white matter (WM) and CSF. Next, the GM probability maps were nonlinearly normalized to standard MNI space. Spatial normalization expands and contracts some brain regions; hence images were modulated in order to keep the total GM equal to the original images. The normalized and modulated images were then smoothed with an 8 mm FWHM Gaussian kernel.


Region-of-interest VBM

We were primarily interested in structural changes within those regions where we found a significant relationship between functional connectivity and ESR. The ROIs were defined as the 8 mm spheres created around the significant peak cluster coordinates from the session 1 network to whole-brain connectivity analyses. We extracted participant-specific raw GM values from the normalized, smoothed GM images for all of the voxels within each ROI and then performed regression analyses to examine the relationship with ESR in STATA 12.1 (adjusting for age, sex and TIV). This procedure was repeated for both session 1 and 2 data. Because we were performing a limited number of tests based on the functional connectivity findings, statistical significance was set at a p-value of 0.05 two-sided without correction.


Whole-brain VBM

We also conducted a whole-brain search for differences in GM volume associated with higher ESR. Smoothed GM images were entered into a multiple regression analysis in SPM8 with ESR as the covariate of interest. All analyses controlled for age, sex and TIV (the sum of GM, WM and CSF). An absolute threshold mask of 0.1 was applied to exclude edge effects and non-homogenous voxels. Results were derived from a whole-brain uncorrected voxel threshold of p < 0.001 and deemed significant at p < 0.05 FDR corrected for multiple comparisons.


Associations with clinical symptoms

To determine whether the significant regions identified through relationships with ESR were also related to clinical symptoms, we used significant clusters extracted from session 1 (as described above in ‘seed network to whole-brain connectivity analysis') in Pearson correlation analyses with current levels of symptoms. We limited these analyses to regions showing relationships with more than one subnetwork due to the potentially large number of comparisons.


Data availability

The data supporting these analyses will be made available following reasonable requests to the corresponding author.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).

  2. 2.

    Andresdottir, M. B., Sigfusson, N., Sigvaldason, H. & Gudnason, V. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am. J. Epidemiol. 158, 844–851 (2003).

  3. 3.

    Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E. & Ridker, P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327–334 (2001).

  4. 4.

    Siemes, C. et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J. Clin. Oncol. 24, 5216–5222 (2006).

  5. 5.

    Chapman, D. P., Perry, G. S. & Strine, T. W. The vital link between chronic disease and depressive disorders. Prev. Chronic Dis. 2, A14 (2005).

  6. 6.

    McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007).

  7. 7.

    Eisenberger, N. I., Inagaki, T. K., Mashal, N. M. & Irwin, M. R. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 24, 558–563 (2010).

  8. 8.

    Harrison, N. A. et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol. Psychiatry 66, 407–414 (2009).

  9. 9.

    Capuron, L. et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643–652 (2002).

  10. 10.

    Prevoo, M. L. et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38, 44–48 (1995).

  11. 11.

    Beckmann, C. F., DeLuca, M., Devlin, J. T. & Smith, S. M. Investigations into resting-state connectivity using independent component analysis. Philos. Trans. R. Soc. B 360, 1001–1013 (2005).

  12. 12.

    Power, J. D. et al. Functional network organization of the human brain. Neuron 72, 665–678 (2011).

  13. 13.

    Zalesky, A., Fornito, A. & Bullmore, E. T. Network-based statistic: identifying differences in brain networks. Neuroimage 53, 1197–1207 (2010).

  14. 14.

    Bullmore, E. & Sporns, O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 10, 186–198 (2009).

  15. 15.

    van den Heuvel, M. P. & Sporns, O. Network hubs in the human brain. Trends Cogn. Sci. 17, 683–696 (2013).

  16. 16.

    Wells, G. et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann. Rheum. Dis. 68, 954–960 (2009).

  17. 17.

    McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).

  18. 18.

    Hess, A. et al. Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc. Natl. Acad. Sci. USA 108, 3731–3736 (2011).

  19. 19.

    Nikolaus, S., Bode, C., Taal, E. & de Laar, M. A. Fatigue and factors related to fatigue in rheumatoid arthritis: a systematic review. Arthritis Care Res. 65, 1128–1146 (2013).

  20. 20.

    Harrison, N. A., Cercignani, M., Voon, V. & Critchley, H. D. Effects of inflammation on hippocampus and substantia nigra responses to novelty in healthy human participants. Neuropsychopharmacology 40, 831–838 (2015).

  21. 21.

    Benson, S. et al. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 153, 794–799 (2012).

  22. 22.

    Kullmann, J. S. et al. Experimental human endotoxemia enhances brain activity during social cognition. Soc. Cogn. Affect. Neurosci. 9, 786–793 (2014).

  23. 23.

    Eisenberger, N. I., Inagaki, T. K., Rameson, L. T., Mashal, N. M. & Irwin, M. R. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47, 881–890 (2009).

  24. 24.

    Salaffi, F., Carotti, M., Gasparini, S., Intorcia, M. & Grassi, W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual. Life Outcomes 7, 25 (2009).

  25. 25.

    Labrenz, F. et al. Alterations in functional connectivity of resting state networks during experimental endotoxemia–an exploratory study in healthy men. Brain Behav. Immun. 54, 17–26 (2016).

  26. 26.

    Vatansever, D., Menon, D. K., Manktelow, A. E., Sahakian, B. J. & Stamatakis, E. A. Default mode network connectivity during task execution. Neuroimage 122, 96–104 (2015).

  27. 27.

    Vatansever, D., Menon, D. K., Manktelow, A. E., Sahakian, B. J. & Stamatakis, E. A. Default mode dynamics for global functional integration. J. Neurosci. 35, 15254–15262 (2015).

  28. 28.

    Reuter-Lorenz, P. A. & Cappell, K. A. Neurocognitive aging and the compensation hypothesis. Curr. Dir. Psychol. Sci. 17, 177–182 (2008).

  29. 29.

    Wallin, K. et al. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J. Alzheimers Dis. 31, 669–676 (2012).

  30. 30.

    Chou, R. C., Kane, M., Ghimire, S., Gautam, S. & Gui, J. Treatment for rheumatoid arthritis and risk of Alzheimer’s disease: a nested case-control analysis. CNS Drugs 30, 1111–1120 (2016).

  31. 31.

    Guo, C. C. et al. Network-selective vulnerability of the human cerebellum to Alzheimer’s disease and frontotemporal dementia. Brain 139, 1527–1538 (2016).

  32. 32.

    Jacobs, H. I. L. et al. The cerebellum in Alzheimer’s disease: evaluating its role in cognitive decline. Brain 141, 37–47 (2018).

  33. 33.

    Loggia, M. L. et al. Evidence for brain glial activation in chronic pain patients. Brain 138, 604–615 (2015).

  34. 34.

    Hillmer, A. T. et al. Microglial depletion and activation: a [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res. 7, 59 (2017).

  35. 35.

    Kreisl, W. C. et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease. Brain 136, 2228–2238 (2013).

  36. 36.

    Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).

  37. 37.

    Chalder, T. et al. Development of a fatigue scale. J. Psychosom. Res. 37, 147–153 (1993).

  38. 38.

    Yarkoni, T. Big correlations in little studies: inflated fMRI correlations reflect low statistical power-commentary on Vul et al. (2009). Perspect. Psychol. Sci. 4, 294–298 (2009).

  39. 39.

    Wolfe, F. & Pincus, T. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness. J. Rheumatol. 28, 1817–1824 (2001).

  40. 40.

    Wang, W. et al. The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 32, 887–893 (2012).

  41. 41.

    Brennan, F. M. & McInnes, I. B. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Investig. 118, 3537–3545 (2008).

  42. 42.

    Sharma, R. et al. The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J. Am. Coll. Cardiol. 36, 523–528 (2000).

  43. 43.

    Hardy, R. et al. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann. Rheum. Dis. 67, 1204–1210 (2008).

  44. 44.

    Pepys, M. B. C-reactive protein fifty years on. Lancet 1, 653–657 (1981).

  45. 45.

    Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J. Rheumatol. 38, 1113–1122 (2011).

  46. 46.

    Cook, D. B., O’Connor, P. J., Lange, G. & Steffener, J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage 36, 108–122 (2007).

  47. 47.

    Basu, N. et al. Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology (Oxf.) 53, 2080–2087 (2014).

  48. 48.

    Cole, M. W., Bassett, D. S., Power, J. D., Braver, T. S. & Petersen, S. E. Intrinsic and task-evoked network architectures of the human brain. Neuron 83, 238–251 (2014).

  49. 49.

    Calhoun, V. D., Adali, T. & Pekar, J. J. A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn. Reson. Imaging 22, 1181–1191 (2004).

  50. 50.

    Smith, S. M. et al. Correspondence of the brain’s functional architecture during activation and rest. Proc. Natl. Acad. Sci. USA 106, 13040–13045 (2009).

  51. 51.

    Whitfield-Gabrieli, S. & Nieto-Castanon, A. Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connect. 2, 125–141 (2012).

  52. 52.

    Birn, R. M. et al. The effect of scan length on the reliability of resting-state fMRI connectivity estimates. Neuroimage 83, 550–558 (2013).

  53. 53.

    Poldrack, R. A. Region of interest analysis for fMRI. Soc. Cogn. Affect. Neurosci. 2, 67–70 (2007).

  54. 54.

    Cohen, A. L. et al. Defining functional areas in individual human brains using resting functional connectivity MRI. Neuroimage 41, 45–57 (2008).

  55. 55.

    Cole, M. W. et al. Multi-task connectivity reveals flexible hubs for adaptive task control. Nat. Neurosci. 16, 1348–1355 (2013).

  56. 56.

    Dosenbach, N. U. et al. Distinct brain networks for adaptive and stable task control in humans. Proc. Natl. Acad. Sci. USA 104, 11073–11078 (2007).

  57. 57.

    Rubinov, M. & Sporns, O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52, 1059–1069 (2010).

  58. 58.

    Sporns, O., Honey, C. J. & Kotter, R. Identification and classification of hubs in brain networks. PLoS ONE 2, e1049 (2007).

  59. 59.

    Ashburner, J. A fast diffeomorphic image registration algorithm. Neuroimage 38, 95–113 (2007).

Download references

Acknowledgements

Special thanks to the patient community who participated in this research effort. Thanks to Mariella D’Allesandro for efforts towards recruitment.

Author information

Affiliations

  1. Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan Health System, Domino’s Farms, Lobby M, PO Box 385, 24 Frank Lloyd Wright Drive, Ann Arbor, MI, 48106, USA

    • Andrew Schrepf
    • , Chelsea M. Kaplan
    • , Eric Ichesco
    • , Tony Larkin
    • , Steven E. Harte
    • , Richard E. Harris
    •  & Daniel J. Clauw
  2. School of Medicine, Medical Sciences and Nutrition, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, UK

    • Alison D. Murray
    • , Gordon D. Waiter
    •  & Neil Basu
  3. Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, G12 8QQ, UK

    • Neil Basu

Authors

  1. Search for Andrew Schrepf in:

  2. Search for Chelsea M. Kaplan in:

  3. Search for Eric Ichesco in:

  4. Search for Tony Larkin in:

  5. Search for Steven E. Harte in:

  6. Search for Richard E. Harris in:

  7. Search for Alison D. Murray in:

  8. Search for Gordon D. Waiter in:

  9. Search for Daniel J. Clauw in:

  10. Search for Neil Basu in:

Contributions

A.S. and C.M.K. contributed equally to this work. Primary analyses and writing were performed by C.M.K., N.B., and A.S. E.I., T.L., R.E.H., S.E.H., and D.J.C. also contributed to data analysis. N.B. was responsible for primary planning and conduct of the experiment; A.D.M. and G.D.W. contributed to this effort as well. All authors contributed to the interpretation and critical revision of the manuscript.

Competing interests

Pfizer provided supplementary funding to N.B. for data acquisition. D.J.C. has consulted or served as an expert witness for Forest Laboratories, Pfizer, Inc, Cerephex Corp, Eli Lilly and Company, Merck & Co, Nuvo Research Inc, Tonix Pharmaceuticals, Johnson & Johnson, Pierre Fabre, Cypress Biosciences, Wyeth Pharmaceuticals, UCB, AstraZeneca, Jazz Pharmaceuticals, Abbott Laboratories, and Iroko Pharmaceuticals. R.E.H. has consulted for Pfizer, Inc. S.E.H. has received research funding from Aptinyx, Cerephex, Eli Lily, Forest Laboratories, and Merck and served as a consultant for Pfizer, Analgesic Solutions, Aptinyx, and deCode Genetics. A.S., C.M.K., S.E.H., R.E.H., T.L., E.I., and D.J.C. have all received funding from the National Institutes of Health. The remaining authors declare no competing interests.

Corresponding author

Correspondence to Andrew Schrepf.

Electronic supplementary material

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41467-018-04648-0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.